NCT02616315View on ClinicalTrials.gov

Efficacy of Naltrexone HCl/Bupropion HCl Extended Release Versus Placebo for Treatment of Weight Regain in Participants Post Bariatric Surgery

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

February 29, 2016

Primary Completion Date

October 31, 2017

Study Completion Date

December 31, 2017

Conditions
Weight Regain Post Bariatric Surgery
Interventions
DRUG

Naltrexone HCl/Bupropion HCl Placebo

Naltrexone/bupropion placebo-matching tablets

DRUG

Naltrexone HCl/Bupropion HCl

Naltrexone HCl 8 mg/bupropion HCl 90 mg tablets

Trial Locations (2)

Unknown

Chicago

Boston

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY